We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

58 hedge funds and large institutions have $154M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

5% more capital invested

Capital invested by funds: $146M → $154M (+$7.48M)

4% more funds holding

Funds holding: 56 → 58 (+2)

Holders
58
Holders Change
+2
Holders Change %
+3.57%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
15
Reduced
8
Closed
6
Calls
$100K
Puts
–
Net Calls
+$100K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
+$6.55M
2
SCM
Saba Capital Management
New York
+$6.01M
3
UOC
UBS O'Connor
Illinois
+$4.2M
4
FTCM
First Trust Capital Management
Illinois
+$3.2M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.75M

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$6.55M
2
Citadel Advisors
Citadel Advisors
Florida
-$6M
3
BCM
Beryl Capital Management
California
-$5.65M
4
MI
MMCAP International
Cayman Islands
-$5M
5
SC
Sculptor Capital
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIMCA
26
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2M – – –
Balyasny Asset Management
27
Balyasny Asset Management
Illinois
$2M – – –
PMAM
28
Picton Mahoney Asset Management
Ontario, Canada
$2M – – –
WA
29
Whitebox Advisors
Minnesota
$2M – – –
CCM
30
Context Capital Management
California
$1.36M – – –
CH
31
CVI Holdings
Delaware
$1.2M – – –
SV
32
Starboard Value
New York
$1.07M – – –
Walleye Capital
33
Walleye Capital
New York
$1.03M -$98.2K -9,820 -9%
JP Morgan Chase
34
JP Morgan Chase
New York
$1M -$989K -98,900 -50%
OCM
35
Oaktree Capital Management
California
$1M – – –
DKCM
36
Davidson Kempner Capital Management
New York
$999K – – –
WAM
37
Wolverine Asset Management
Illinois
$837K -$110K -11,037 -12%
ECU
38
Eisler Capital (UK)
United Kingdom
$803K +$801K +80,145 New
Walleye Trading
39
Walleye Trading
New York
$631K – – –
Citigroup
40
Citigroup
New York
$501K – – –
LA
41
Linden Advisors
New York
$450K -$6.55M -655,068 -94%
CC
42
Centiva Capital
New York
$436K +$136K +13,644 +46%
DAM
43
DLD Asset Management
New York
$433K – – –
KC
44
Kryger Capital
United Kingdom
$421K -$20.6K -2,065 -5%
GCL
45
Glazer Capital LLC
New York
$336K +$24.4K +2,436 +8%
BFM
46
Boothbay Fund Management
New York
$322K +$5.94K +594 +2%
ASM
47
ATW SPAC Management
New York
$316K – – –
LCM
48
Lynwood Capital Management
Ontario, Canada
$315K – – –
SAMU
49
SONA Asset Management (US)
New York
$301K – – –
WP
50
Woodline Partners
California
$287K +$36.5K +3,650 +15%
1
2
3

IQMD Hedge Fund Activity: Q2 2022 in Review

58 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q2 2022, worth a combined $154M — up 5.1% from $146M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new IQMD positions and 6 closed out — a net gain of 2 holders — while 15 added to existing stakes and 8 trimmed.

The largest buyer was HSBC Holdings, opening a new position worth an estimated $6.55M. The largest seller was Linden Advisors, cutting an estimated $6.55M.

  • 58 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q2 2022, up from 56 in Q1 2022.
  • Funds reported $154M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q2 2022, up 5.1% quarter-over-quarter.
  • 8 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q2 2022 and 6 closed out, a net change of +2 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q2 2022 was HSBC Holdings, an estimated $6.55M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q2 2022 was Linden Advisors, an estimated $6.55M sold.

Based on aggregated 13F filings for Q2 2022.